2 result(s) displayed (1 - 2 of 2):

Lilly's prescription for growth (from Corporate Dealmaker)

Eli Lilly and Co. spent $2.4 billion on life-science R&D last year, exploring everything from antisense technology to synthetic exendin-4. But the biggest experiment under way at the company isn't taking place in a lab or a clinic. And the results of that experiment - highly promising so far...

Posted on August 15, 2004 5:45 PM

So how do you manage an alliance? (from Corporate Dealmaker)

Patricia Martin has been an energetic advocate, both inside and outside Eli Lilly and Co., for a simple idea. "There's life after the deal," she says. "And it's worth paying attention to." That in a nutshell is the mission of Lilly's Office of Alliance Management, which monitors, supports and helps...

Posted on August 15, 2004 2:44 PM